Source: Element Nutritional Sciences.
  • Element Nutritional (ELMT) has completed production trials for its Rejuvenate Muscle Activator
  • The drink enables muscle protein synthesis 150 per cent greater than whey protein powder
  • The company intends to launch the product online and in U.S. brick-and-mortar in Q3 2022
  • Element Nutritional Sciences is a nutraceutical company focused on consumers over the age of 50
  • Element Nutritional (ELMT) is up by 13.04 per cent trading at $0.26 per share

Element Nutritional (ELMT) has completed production trials for its Rejuvenate Muscle Activator.

Rejuvenate is a ready-to-drink beverage based on Element’s patented amino acid formulation. It has been proven to result in muscle protein synthesis of 57 per cent, which is estimated to be 150 per cent greater compared to the average whey-based protein powder.

The company expects to launch the product online and through its U.S. pharmacy and grocery retail network in Q3 2022. It also intends to market Rejuvenate to hospitals and health care facilities.

The U.S. functional beverage market is estimated to be over US$48B, growing to over US$66B by 2025 (Euromonitor).

“Our new patented Rejuvenate Muscle Activator is proven to be more effective than whey protein and has the potential to disrupt the entire whey protein market,” stated Stuart Lowther, Element’s CEO. “Leveraging our proprietary amino acid formulation into new functional beverage categories is a key driver to our growth strategy and Rejuvenate Muscle Activator will increase our profitability by 15% to 20% as compared to our current portfolio of ready-to-drink beverages.”

Element Nutritional Sciences is a nutraceutical company focused on consumers over the age of 50.

Element Nutritional (ELMT) is up by 13.04 per cent trading at $0.26 per share as of 10:31 am EST.

More From The Market Online

Air Canada adds new in-flight sports channels before NHL playoffs

Air Canada (TSX:AC) adds three new live TV sports channels for its in-flight entertainment system just in time for the Stanley Cup Playoffs

Thomson Reuters expands its GenAI assistant

Thomson Reuters (TSX:TRI) has revealed the expanded vision for its professional-grade GenAI assistant, CoCounsel.